Versiti Michigan Inc
VERSITI MICHIGAN, INC. (VERSITI) IS A BLOOD HEALTH INNOVATOR WHICH ENHANCES LIVES THROUGH DISCOVERY, DIAGNOSIS AND TREATMENT. VERSITI EXPANDS THE FRONTIERS OF PATIENT HEALTH THROUGH THE INTEGRATION OF SCIENCE, MEDICINE AND SERVICE.
Financial Overview
From 2024 IRS Form 990-PF
Total Assets
$49.4M
+10.5% YoY
Annual Giving
—
Grant Count
0
Avg Grant Size
—
Go deeper than public filings
PRO- Giving trend analysis — growing or declining?
- Organizations like yours that won grants here
- Strategic fit assessment for your organization
- Application timing recommendations
Financial History
Multi-year comparison from IRS filings
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Total Assets | $49,437,276 | $44,741,001 | $40,583,920 |
| Revenue | $74,790,441 | $69,044,445 | $65,203,787 |
| Expenses | $69,635,492 | $65,377,053 | $63,869,912 |
| Qualifying Distributions | — | — | — |
| Net Investment Income | $139,594 | $1,130,428 | $1,022,800 |
| Distributable Amount | — | — | — |
Giving Over Time
Total grant dollars and number of grants per year
Grant Insights
How this funder distributes its grants
Top Recipients
Top 0 recipients in 2024
Grant Size Distribution
3 grants across all recorded years
Giving History
Grant recipients and amounts by year
No grants recorded for .
Who else does Versiti Michigan Inc fund?
Explore the funder–grantee relationships behind this foundation, powered by GrantGraph™ — our database of 11 million+ funding connections.
- Similar orgs that won grants here
- GrantGraph™ relationship mapping
- 11M+ connections in GrantGraph™
Key People
Officers and directors from IRS filings
Compensation Overview
From 2024 IRS filing
From 2024 filing
| Name | Title | Hours | Compensation |
|---|---|---|---|
| CHRIS MISKEL | PRESIDENT & CEO | 11 | $324,520 |
| FRED GEILFUSS | CHAIR | 1 | — |
| L ALAN WHALEY | VICE CHAIR | 1 | — |
| COREEN DICUS-JOHNSON JD | SECRETARY | 1 | — |
| RON MILLER | TREASURER | 1 | — |
| NICHOLAS BAUER | BOARD MEMBER | 1 | — |
| DAVID GINSBURG MD | BOARD MEMBER | 1 | — |
| CECELIA GORE | BOARD MEMBER | 1 | — |
| GAIL HANSON | BOARD MEMBER | 1 | — |
| THOMAS HAUSKE JR | BOARD MEMBER | 1 | — |
| SHERRY HUSA | BOARD MEMBER | 1 | — |
| DALE KENT | BOARD MEMBER | 1 | — |
| ROBERT H MANEGOLD | BOARD MEMBER | 1 | — |
| JEFFREY S MCDONALD | BOARD MEMBER | 1 | — |
| MAGGEY OPLINGER | BOARD MEMBER | 1 | — |
| JOHN PERRAS | BOARD MEMBER | 1 | — |
| KATHY THORNTON-BIAS | BOARD MEMBER - THRU 6/24 | 1 | — |
| GREG WESLEY | BOARD MEMBER | 1 | — |
| PETER ZIEGLER | BOARD MEMBER | 1 | — |
| BRIAN BAUTISTA | EVP & CHIEF OPERATING OFFICER | 11 | $162,553 |
| GITESH DUBAL | EVP & CHIEF MKTG. OFF. - THRU 4/24 | 11 | $81,412 |
| ANTHONY WATKINS | EVP&CFO-THRU 3/24;BUS DEV-AS OF 3/24 | 11 | $149,743 |
| JAMES WEIDNER | EVP & CHIEF HR OFFICER | 11 | $114,320 |
| LYNNE BRIGGS | VP & CHIEF INFORMATION OFFICER | 11 | $96,373 |
| BART REUTER | EVP & GENERAL COUNSEL | 11 | $172,320 |
| BRADLEY PIETZ | EVP & CHIEF LABORATORY OFFICER | 11 | $120,183 |
| JESSICA DROUILLARD | VP & CHIEF QUALITY OFFICER | 11 | $55,208 |
| MICHAEL DEININGER MD | EVP & CHIEF SCIENTIFIC OFFICER | 1 | — |
| BARBARA BRYANT | EVP & CHIEF MED. OFF. - THRU 8/24 | 1 | — |
| GRETCHEN JAMESON | EVP & CHIEF MKTG. OFF. - AS OF 4/24 | 11 | $44,083 |
| DEREK TYUS | EVP & CHIEF FINANCIAL OFF. - AS 3/24 | 11 | $90,460 |
| MATTHEW ANDERSON MD | EVP & CHIEF MED. OFF. - AS OF 7/24 | 1 | — |
| TIMOTHY PANCIOLI DO | ASSOCIATE MEDICAL DIRECTOR | 55 | $253,383 |
| PERPETUE U BARIYANGA | SR REG NURSE THERAPEUTIC SERVICES | 55 | $178,958 |
| KRISTIN RONCHETTI-BRENNER | AVP & SR DIRECTOR DONOR SERVICES | 55 | $177,260 |
| MICHELLE MAMBY | SR REG NURSE THERAPEUTIC SERVICES | 55 | $174,672 |
| DAWN KAISER | DIRECTOR DONOR SERVICES | 55 | $151,232 |
Geographic Focus
Where this funder has awarded grants
Grant Distribution by State
Cities
Data last updated March 2026. Sourced from IRS Form 990-PF filings.
What could you do with Versiti Michigan Inc on Grantable?
- Assess strategic fit with your organization
- Get AI-generated opportunity briefs
- Monitor for new funding opportunities
- Draft a tailored letter of inquiry